The OPTIN Contact Bulletin

New Projects in

NEUROLOGICAL DISORDERS

from Israel

No.11 – February 2003

www.optin.nl

Projects:

1.    Blocking neuronal death: a novel approach to treating neurological disorders

2.    Novel strategy: small molecular weight compounds for the treatment of oxidative stress-indued neurodegenerative disorders

3.    Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders

4.    A novel anti-inflammatory protein for the treatment of multiple sclerosis

5.    Development of antisense – based compounds that can cross the blood brain barrier for the treatment of CNS disorders

6.    Genome-based cholinergic approach to neurological disorders

7.    Hearing loss: deciphering genetics of the most common sensory defect in humans

8.    Novel therapeutics for neurological disorders

9.    Novel brain-targeted compounds for the reatment of neurodegenerative disorders

10. Novel therapeutic products for the treatment of a wide range neurological disorders

11. Recombinant fragments of the human acetylcholine receptor: application for the treatment of myasthenia gravis

12. Cell therapies and other treatment strategies for neurological disorders

13. New antiepileptic and CNS drugs: valproyl taurinamide and Its N-Alkylated derivatives

14. Technology for delivering drugs to the central nervous system (CNS)

15. Synthetic genes and their products for potential immune-specific therapy of autoimmune diseases

16. Antisense technology for CNS diseases

17. Lipophilic iron chelators for the transdermal treatment of haemachromatosis and iron loading conditions affecting cardiovascular exocrine and neurological systems

18. Neuromuscular electrical stimulation systems

19. Image enhancement for the visually impaired

20. Compounds for oral treatment of central nervous system (CNS) disorders

21. Platform for transdermal delivery of neurological drugs

22. Products for the central nervous system (CNS)

In the News:

1.     Tests Alzheimer`s Drugs for H.Lundbeck MindGenix

2.     Novel Communication Solution for Persons with Limited Motor Abilities

Coming up in the next bulletin

New Projects in ‘”Medical and Environmental Diagnostics”

For background and contact information on the listed projects  please contact Optin’s L.S. Manager: e.guetta@optin.nl

For extra information and benefits specifically for sponsors, please contact OPTIN: optin@optin.nl

For more information about Life Sciences in Israel and in The Netherlands see the OPTIN site: www.optin.nl , your portal to Israeli and Dutch biotechnology.

For previous Bulletins click on Projects at www.optin.nl

Events

MEDICA 2003

4-7 March 2003, Jaarbeurs, Utrecht, The Netherlands

INTERNATIONAL BIO-TECH ISRAEL 2003

13-15 May 2003, Tel Aviv,  Israel

NEW INNOVATIVE TECHNOLOGIES IN MEDICINE

FROM ISRAEL AND THE NETHERLANDS

17-18 September 2003, The Hague, The Netherlands

Sponsors

DSM Venturing

IBM Life Sciences

Tel Aviv University

Hoekert’s creations

WFIA/ Israeli Office Delft

The Embassy of Israel

CIDI

Matimop

Nmedica

Contributors

Tel Aviv University/ Ramot

The Hebrew University/ Yissum

Weizmann Institute/ Yeda

Bar Ilan University

Ben-Gurion University

Hadasit

Technion

Matimop

Announcement

Tel Aviv university has published the EOI's for the Sixth Framework on the web, and invites interested partners from the Netherlands (academy and industry) to join the consortia being formed. Contact can be made directly with the coordinator of each group or with the EU liason Office at the address on the web site:

EOI's for the Sixth Framework